Dr. Marie Elisabeth Detienne, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1686 Eatonton Rd, Madison, GA 30650 Phone: 706-342-0550 Fax: 706-342-3736 |
Dr. Forest Reed Pagett, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 139 E Jefferson St, Madison, GA 30650 Phone: 706-342-3636 |
Dr. Joshua Evans Whetzel, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 139 E Jefferson St, Madison, GA 30650 Phone: 706-342-3636 Fax: 706-342-4273 |
Dr. Michael Clinton Montgomery, D.M.D.,P.C. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1040 Barclay Dr, Madison, GA 30650 Phone: 706-342-1242 |
O. Adrian Woodruff Jr., DMD, PC Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 480 Hancock St, Madison, GA 30650 Phone: 706-342-2155 Fax: 706-343-1080 |
Dr. James E Paschal Jr., DMD, MS Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 153 W Washington St, Madison, GA 30650 Phone: 706-342-7330 Fax: 678-559-0756 |
Charles J Scherer Iii Dentist Medicare: Medicare Enrolled Practice Location: 2151 Eatonton Hwy, Bldg D, Madison, GA 30650 Phone: 706-752-1910 |
News Archive
Prairie dogs, once abundant in the Rocky Mountains and Great Plains, have been decimated in recent decades by plague - a virulent bacterial disease spread by fleas.Plague outbreaks periodically sweep through large prairie dog towns with thousands of inhabitants, killing virtually the entire population within months. Other prairie dogs move in and build a new colony, which eventually is wiped out when the disease returns.
Europe's most promising oncology biotechs and other key stakeholders will gather in Oslo, Norway, September 15-17 for the 2nd European Cancer Cluster Meeting (ECCP 2010). Co-hosted by the Oslo Cancer Cluster and the Cancer-Bio-Santé Cluster from Toulouse, the two-day meeting is a unique partnering opportunity for oncology biotech companies, business development and licensing executives from the pharmaceutical industry and investors, as well as innovative researchers and clinicians.
Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.
Johns Hopkins scientists have created a free, Web-based tool to help patients decide whether it's best to accept an immediately available, but less-than-ideal deceased donor kidney for transplant, or wait for a healthier one in the future.
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge, and the AstraZeneca IMED Biotech Unit reveals new insights into how the PTEN gene may control cell growth and behavior and how its loss contributes to the development and advancement of certain cancers.
› Verified 6 days ago